Parasite infections in multiple sclerosis modulate immune responses through a retinoic acid-dependent pathway

Journal of Immunology

Volumn 191, Issue 7, 2013, Pages 3827-3837

  Correale, Jorge ^a   Farez, Mauricio F ^a  

^a Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALCOHOL DEHYDROGENASE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; IVERMECTIN; MITOGEN ACTIVATED PROTEIN KINASE; PARASITE ANTIGEN; PROTEIN ADH1; PROTEIN RALDH2; PROTEIN SEA; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOL DEHYDROGENASE; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GENE EXPRESSION; GENE SILENCING; HELMINTHIASIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REGULATORY T LYMPHOCYTE; SCHISTOSOMA MANSONI; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE;

ALCOHOL DEHYDROGENASE; ANTIGENS, HELMINTH; CYTOKINES; DENDRITIC CELLS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLAMMATION MEDIATORS; MALE; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; PARASITIC DISEASES; RECEPTORS, RETINOIC ACID; RETINAL DEHYDROGENASE; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES, REGULATORY; TRETINOIN;

EID: 84885136862     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301110     Document Type: Article

References (56)

1. McFarland, H. F., and R. Martin. 2007. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8:913-919.
2. Oksenberg, J. R., S. E. Baranzini, S. Sawcer, and S. L. Hauser. 2008. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat. Rev. Genet. 9:516-526.
3. Marrie, R. A. 2004. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 3:709-718.
4. Ebers, G. C., D. E. Bulman, A. D. Sadovnick, D. W. Paty, S. Warren, W. Hader, T. J. Murray, T. P. Seland, P. Duquette, T. Grey, et al. 1986. A population-based study of multiple sclerosis in twins. N. Engl. J. Med. 315:1638-1642.
5. Bach, J. F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347:911-920.
6. Fleming, J. O., and T. D. Cook. 2006. Multiple sclerosis and the hygiene hypothesis. Neurology 67:2085-2086.
7. Sewell, D., Z. Qing, E. Reinke, D. Elliot, J. Weinstock, M. Sandor, and Z. Fabry. 2003. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int. Immunol. 15:59-69.
8. La Flamme, A. C., K. Ruddenklau, and B. T. Bäckström. 2003. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect. Immun. 71:4996-5004.
9. Correale, J., and M. Farez. 2007. Association between parasite infection and immune responses in multiple sclerosis. Ann. Neurol. 61:97-108.
10. Correale, J., and M. F. Farez. 2011. The impact of parasite infections on the course of multiple sclerosis. J. Neuroimmunol. 233:6-11.
11. Mora, J. R., M. Iwata, and U. H. von Andrian. 2008. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol. 8:685-698.
12. Petkovich, M., N. J. Brand, A. Krust, and P. A. Chambon. 1987. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444-450.
13. Mangelsdorf, D. J., U. Borgmeyer, R. A. Heyman, J. Y. Zhou, E. S. Ong, A. E. Oro, A. Kakizuka, and R. M. Evans. 1992. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 6:329-344.
14. Hall, J. A., J. R. Grainger, S. P. Spencer, and Y. Belkaid. 2011. The role of retinoic acid in tolerance and immunity. Immunity 35:13-22.
15. Winoto, A., and D. R. Littman. 2002. Nuclear hormone receptors in T lymphocytes. Cell 109:S57-S66.
16. Correale, J., and M. Farez. 2009. Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. J. Immunol. 183:5999-6012.
17. Becker, I., N. Salaiza, M. Aguirre, J. Delgado, N. Carrillo-Carrasco, L. G. Kobeh, A. Ruiz, R. Cervantes, A. P. Torres, N. Cabrera, et al. 2003. Leishmania lipophosphoglycan (LPG) activates NK cells through Toll-like receptor-2. Mol. Biochem. Parasitol. 130:65-74.
18. Hartgers, F. C., B. B. Obeng, A. Voskamp, I. A. Larbi, A. S. Amoah, A. J. F. Luty, D. Boakye, and M. Yazdanbakhsh. 2008. Enhanced Toll-like receptor responsiveness associated with mitogen-activated protein kinase activation in Plasmodium falciparum-infected children. Infect. Immun. 76:5149-5157.
19. Kane, C. M., E. Jung, and E. J. Pearce. 2008. Schistosoma mansoni egg antigenmediated modulation of Toll-like receptor (TLR)-induced activation occurs independently of TLR2, TLR4, and MyD88. Infect. Immun. 76:5754-5759.
20. Kawai, T., and S. Akira. 2005. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 17:338-344.
21. Boros, D. L., R. Tomford, and K. S. Warren. 1977. Induction of granulomatous and elicitation of cutaneous sensitivity by partially purified SEA of Schistosoma mansoni. J. Immunol. 118:373-376.
22. Correale, J., and M. Farez. 2007. Monocyte-derived dendritic cells in multiple sclerosis: the effect of bacterial infection. J. Neuroimmunol. 190:177-189.
23. Correale, J., M. McMillan, K. McCarthy, T. Le, and L. P. Weiner. 1995. Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients. Neurology 45:1370-1378.
24. Molenaar, R. M., M. Knippenberg, G. Goverse, B. J. Olivier, A. F. de Vos, T. O'Toole, and R. E. Mebius. 2011. Expression of retinaldehyde dehydrogenase enzymes in mucosal dendritic cells and gut-draining lymph node stromal cells is controlled by dietary vitamin A. J. Immunol. 186:1934-1942.
25. Manicassamy, S., R. Ravindran, J. Deng, H. Oluoch, T. L. Denning, S. P. Kasturi, K. M. Rosenthal, B. D. Evavold, and B. Pulendran. 2009. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat. Med. 15:401-409.
26. Blomhoff, R., and H. K. Blomhoff. 2006. Overview of retinoid metabolism and function. J. Neurobiol. 66:606-630.
27. Tone, Y, K. Furuuchi, Y. Kojima, M. L. Tykocinski, M. I. Greene, and M. Tone. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9:194-202.
28. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189.
29. Dimitriou, I. D., L. Clemenza, A. J. Scotter, G. Chen, F. M. Guerra, and R. Rottapel. 2008. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol. Rev. 224:265-283.
30. Correale, J., M. Farez, and G. Razzitte. 2008. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann. Neurol. 64:187-199.
31. Maden, M. 2007. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat. Rev. Neurosci. 8:755-765.
32. Besler, H. T., S. Comoglu, and Z. Okçu. 2002. Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr. Neurosci. 5:215-220.
33. Royal, W., III, S. Gartner, and C. D. Gajewski. 2002. Retinol measurements and retinoid receptor gene expression in patients with multiple sclerosis. Mult. Scler. 8:452-458.
34. Løken-Amsrud, K. I., K.-M. Myhr, S. J. Bakke, A. G. Beiske, K. S. Bjerve, B. T. Bjørnara, H. Hovdal, F. Lilleas, R. Midgard, T. Pedersen, et al. 2013. Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Mult. Scler. 19:451-457.
35. Racke, M. K., D. Burnett, S.-H. Pak, P. S. Albert, B. Cannella, C. S. Raine, D. E. McFarlin, and D. E. Scott. 1995. Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course. J. Immunol. 154:450-458.
36. Kinoshita, K., B. S. Yoo, Y. Nozaki, M. Sugiyama, S. Ikoma, M. Ohno, M. Funauchi, and A. Kanamaru. 2003. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice. J. Immunol. 170:5793-5798.
37. Nozaki, Y, T. Yamagata, M. Sugiyama, S. Ikoma, K. Kinoshita, and M. Funauchi. 2006. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Clin. Immunol. 119:272-279.
38. Iwata, M., A. Hirakiyama, Y. Eshima, H. Kagechika, C. Kato, and S. Y Song. 2004. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21:527-538.
39. Coombes, J. L., K. R. R. Siddiqui, C. V. Arancibia-Carcamo, J. Hall, C. M. Sun, Y. Belkaid, and F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-p and retinoic acid-dependent mechanism. J. Exp. Med. 204:1757-1764.
40. Mucida, D., Y. Park, G. Kim, O. Turovskaya, I. Scott, M. Kronenberg, and H. Cheroutre. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256-260.
41. Guilliams, M., K. Crozat, S. Henri, S. Tamoutounour, P. Grenot, E. Devilard, B. de Bovis, L. Alexopoulou, M. Dalod, and B. Malissen. 2010. Skin-draining lymph nodes contain dermis-derived CD103 (-) dendritic cells that constitutively produce retinoic acid and induce Foxp3 (+) regulatory T cells. Blood 115:1958-1968.
42. Mora, J. R., Jr., M. Iwata, B. Eksteen, S. Y Song, T. Junt, B. Senman, K. L. Otipoby, A. Yokota, H. Takeuchi, P. Ricciardi-Castagnoli, et al. 2006. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314:1157-1160.
43. Wiedermann, U., L. A. Hanson, H. Kahu, and U. I. Dahlgren. 1993. Aberrant T-cell function in vitro and impaired T-cell dependent antibody response in vivo in vitamin A-deficient rats. Immunology 80:581-586.
44. Iwata, M., Y. Eshima, and H. Kagechika. 2003. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int. Immunol. 15:1017-1025.
45. Lovett-Racke, A. E., and M. K. Racke. 2002. Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cells. Cell. Immunol. 215:54-60.
46. Dawson, H. D., G. Collins, R. Pyle, M. Key, A. Weeraratna, V. Deep-Dixit, C. N. Nadal, and D. D. Taub. 2006. Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol. 7:27.
47. Hall, J. A., J. L. Cannons, J. R. Grainger, L. M. Dos Santos, T. W. Hand, S. Naik, E. A. Wohlfert, D. B. Chou, G. Oldenhove, M. Robinson, et al. 2011. Essential role for retinoic acid in the promotion of CD4 (+) T cell effector responses via retinoic acid receptor alpha. Immunity 34:435-447.
48. Schambach, F., M. Schupp, M. A. Lazar, and S. L. Reiner. 2007. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur. J. Immunol. 37:2396-2399.
49. Xiao, S., H. Jin, T. Korn, S. M. Liu, M. Oukka, B. Lim, and V. K. Kuchroo. 2008. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181:2277-2284.
50. Xu, L., A. Kitani, and W. Strober. 2010. Molecular mechanisms regulating TGF-beta-induced Foxp3 expression. Mucosal Immunol. 3:230-238.
51. Nolting, J., C. Daniel, S. Reuter, C. Stuelten, P. Li, H. Sucov, B. G. Kim, J. J. Letterio, K. Kretschmer, H. J. Kim, and H. von Boehmer. 2009. Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines. J. Exp. Med. 206:2131-2139.
52. Uematsu, S., K. Fujimoto, M. H. Jang, B. G. Yang, Y. J. Jung, M. Nishiyama, S. Sato, T. Tsujimura, M. Yamamoto, Y. Yokota, et al. 2008. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 9:769-776.
53. Bai, A., N. Lu, H. Zeng, Z. Li, X. Zhou, J. Chen, P. Liu, Z. Peng, and Y. Guo. 2010. All-trans retinoic acid ameliorates trinitrobenzene sulfonic acid-induced colitis by shifting Th1 to Th2 profile. J. Interferon Cytokine Res. 30:399-406.
54. Van, Y. H., W. H. Lee, S. Ortiz, M. H. Lee, H. J. Qin, and C. P. Liu. 2009. Alltrans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells. Diabetes 58:146-155.
55. Kamda, J. D., and S. M. Singer. 2009. Phosphoinositide 3-kinase-dependent inhibition of dendritic cell interleukin-12 production by Giardia lamblia. Infect. Immun. 77:685-693.
56. Wang, S., E. J. Villablanca, J. De Calisto, D. C. O. Gomes, D. D. Nguyen, E. Mizoguchi, J. C. Kagan, H.-C. Reinecker, N. Hacohen, C. Nagler, et al. 2011. MyD88-dependent TLR1/2 signals educate dendritic cells with gut-specific imprinting properties. J. Immunol. 187:141-150.